Cure
Overview
These Boston area conferences bring together leading scientists, entrepreneurs, industry executives, and investors to share the latest research, explore therapeutic discoveries, and shape the future of medicines and therapies.
Boston runs on biotech, and its conference calendar is evidence. The dozen events below span July through November 2026 and cover mRNA, bioprocessing, cell and gene therapy, RNA, obesity, and the finance and accounting that keep all of it moving.
Several cluster into one week. Biotech Week Boston stacks multiple co-located events into four days in late September, so a single trip can cover cell and gene therapy, RNA, and biomanufacturing back to back in the same building. Costs run from free to more than $5,000, and several events offer early-bird rates that expire over the summer.
mRNA-Based Therapeutics Summit
Date: July 20–22, 2026 Location: Westin Boston Seaport District; Boston, MA Purpose: mRNA technology breakthroughs, strategic insights, and collaboration opportunities Scale: 250+ global leaders Cost: Fees range from $2,699 to $5,297
mRNA-Based Therapeutics Summit includes a three-track agenda that covers discovery, pre-clinical and clinical development, and manufacturing and CMC, as well as AI-Driven mRNA design and next-gen delivery technologies. Sessions include topics like advancing in vivo CAR-T programming with mRNA, enhancing potency and expression with novel RNA modalities, building strong partnerships to accelerate mRNA development, and more.
Speakers include Christina Vorvis, PhD, director of East Coast Ventures at AbbVie, Nikhil Adi, Senior Principal Scientist at Pfizer, George Thom, Director and mRNA team Leader at AstraZeneca, and more. Newly combined teams from acquisitions like Eli Lilly and Orna, BMS and Orbital, AbbVie and Capstan, and BioNTech and CureVac will announce what their combined pipelines look like.
Bioprocessing Summit
Date: August 10–13, 2026 Location: Omni Boston Hotel at the Seaport, Boston; virtual Purpose: Innovation and digitalization of gene therapy/RNA/LNPs, cell therapy Scale: Over 1,100 attendees and 70 exhibitors Cost: ~$1,699–$1,999 for 2 days; ~$2,599–$2,999 for 4 days; 20% group discount for teams of 2+; book hotel in the room block by July 10 to save an additional $100
The Bioprocessing Summit unites a global community of scientists, engineers, and executives driving innovation and digitalization across process development, scale-up, quality, and analytics for biologics, antibodies, cell and gene, RNA, and oligonucleotide therapies. Participants can attend in-person or virtually and can choose from over 300 educational and technical presentations, interactive panels, and plenary keynotes. Topics include upstream and downstream processing, AI digitalization, RNA genetic medicine, cell and gene therapy, and more. Speakers include Weichang Zhou, PhD, CTO at MediLink Therapeutics, Jennitte L Stevens, PhD, Chief Technical Operations Officer at insitro.
Biotech Week Boston
Date: September 22–25, 2026 Location: Boston, MA (Hynes Convention Center and nearby venues) Purpose: Festival of co-located events, including BioProcess International, Cell & Gene Therapy International, RNA Leaders USA Congress, LSX USA Congress, and Obesity Science & Innovation Scale: 5,000+ global attendees from 48 countries Cost: Varies for each event; see each event below
Biotech Week Boston is unlike any of its prior editions as it connects biotech, academia, investors, and service providers all at the same event across the week. This year, BioPharm America has merged into LSX USA, which means North America's leading biotech CEO partnering event and the top European-style investment forum now run as one conference. Each event requires a separate registration and fee.
Cell & Gene Therapy International (CGTI)
Date: September 22–25, 2026 Location: Hynes Convention Center; Boston, MA (part of Biotech Week Boston) Purpose: Cell and gene therapy development, manufacturing, and commercialization Scale: 3,000+ scientists, researchers, clinicians, manufacturing experts, and industry leaders Cost: $2,799 to $3,699
CGTI is the premier global conference dedicated to advancing cell and gene therapy development, manufacturing, and commercialization. Attendees can choose from three tracks and two workshops, including development of emerging cell and gene therapies, applications for solid tumors, and more. Speakers include Stephan O. Krause, PhD, Executive Director of Analytical Strategy, Cell Therapies Global Quality at Bristol Myers Squibb, Nelly Viseux, Vice President of Cell Therapies Development, Manufacturing, Supply & Quality at Regeneron, and more.
As part of Biotech Week Boston, attendees can go to this, as well as RNA Leaders and BioProcess International back-to-back in the same building across four days.
RNA Leaders USA Congress
Date: September 23–25, 2026 Location: Hynes Convention Center; Boston, MA (part of Biotech Week Boston) Purpose: Advancements in RNA science Scale: 300+ attendees, including C-suite, pharmaceutical leaders, academic researchers, investors, and regulatory experts Cost: Approximate costs include $2,599 if booked by June 5; $3,899 after June 5
RNA Leaders USA Congress covers advancements in RNA science including RNA-based therapies, vaccines, diagnostics, and emerging technologies like RNA editing and delivery systems, as well as regulatory challenges and strategies for commercialization. Speakers include Anders M. Näär, professor of metabolic biology at UC Berkeley, Annette Bak, PhD, MBA, at AstraZeneca, Edward Miracco, PhD, Director at Moderna, Inc., and more. Attendees can participate in a unique, private networking opportunity at the Boston Museum of Science.
Obesity Science & Innovation
Date: September 23–24, 2026 Location: Hynes Convention Center; Boston, MA (part of Biotech Week Boston) Purpose: Cutting-edge obesity research and metabolic health advancements Scale: 150+ attendees Cost: Approximately $1,500–$3,000
Obesity Science & Innovation covers emerging obesity therapeutics with sessions about GLP-1 and combination agonist clinical trials, RNA-based approaches (siRNA, non-coding RNA) for obesity, adipose-targeted energy expenditure therapies, and muscle preservation strategies (SAR modulation, precision antibodies). Some speakers include Peng Leong, CBO of BioAge Labs, Olivier Boss, CSO and Founder of Energesis Pharmaceuticals, Laura Holberger, PhD, MBA, at Novo Nordisk and others.
Life Sciences Product Launch Summit 2026
Date: September 22, 2026 Location: Hynes Convention Center; Boston, MA (part of Biotech Week Boston) Purpose: One-day, focused summit for commercial professionals in life sciences Cost: ~$1,000–$2,000; reduced rate if booked by June 26
Life Sciences Product Launch Summit 2026 occurs on the opening day of BioProcess International. The day includes information about market access, pricing strategy, distribution optimization, and product launch execution across rare disease and non-specialty markets. Topics include pre-launch planning, distribution model selection, rare disease and specialty market strategies, innovative pricing models, and post-launch governance to maintain team integration beyond day one. All delegates get complimentary access to Streamly, Informa’s on-demand platform, for up to 12 months after the event.
BioProcess International (BPI) Boston 2026
Date: September 22–25, 2026 Location: Hynes Convention Center; Boston, MA (part of Biotech Week Boston) Purpose: Biomanufacturing, regulatory deep-dives, and digitalization Scale: 3,000+ bioprocessing professionals Cost: ~$799 to ~$3,899; early bird discounts available
The BPI event focuses on established biomanufacturing, regulatory deep-dives, and digitalization. Sessions cover topics such as a hands-on guide to build and use AI tools, requirements from pre-clinical to phase 2 CT, and mechanistic versus AI models. Speakers include Jack Prior, Head of Process Monitoring & Data Science/AI Strategy at Sanofi, Alaina Anand, Scientist at Pfizer, and more.
LSX USA Congress
Date: September 22-24, 2026 Location: Hynes Convention Center, Boston, MA (part of Biotech Week Boston) Purpose: Early- and mid-stage biotech fundraising, partnering, licensing, investor networking Scale: 1,000+ senior attendees, 2,000+ partnering meetings, and 250+ investors Cost: Registration ranges from $2,295 to $5,245; investors may receive free access if registered early
LSX USA Congress is a biotech fundraising and partnering conference designed specifically to connect emerging and growth-stage life science companies with venture capital, private equity, and pharmaceutical business development leaders. Strong emphasis on curated 1:1 meetings and investment opportunities. Focused content includes early innovation and technology translation, capital markets and investment strategies, pharma partnering and deal making, and market opportunities and commercialization.
Key speakers include Scott DeWire, PhD, Corporate Senior Vice President and Global Head of Business Development & Licensing at Boehringer Ingelheim, Brian Goodman, Managing Director at Vida Ventures, Elena Diez Cecilia, Senior Director External Innovation DPDS at Johnson & Johnson, and more. Attendees can showcase their company to influential life science investors and pharma executives. Participants can also engage in speed networking with biotechs, pharmaceutical companies, investors, and industry leaders to seek funding, explore licensing opportunities, or build strategic alliances.
STAT Summit in Boston
Date: October 14-15, 2026 Location: State Room, Boston; virtual Purpose: Convening the year’s biggest newsmakers in health and medicine Scale: 400+ leaders hand-selected by STAT’s editorial team Cost: ~$200–$1,600; discounted rates until June 30 and available for startups, academia, nonprofits, and students
STAT Summit Boston brings together the most influential people in biotech, pharma, and health policy, including patients, policymakers, and advocates to debate, reflect, and shape the future of health and medicine in an intimate environment. Speakers include Anthony Fauci, MD, Distinguished University Professor at Georgetown University School of Medicine, McCourt School of Public Policy, Gunnar Esiason, Vice President of Patient Strategy and Innovation at Raven, and more.
MGB Gene and Cell Therapy Research Symposium
Date: November 4–5, 2026 Location: Mass General Brigham Assembly Row; Somerville, MA Purpose: Advancing gene and cell therapy innovations, accelerating clinical translation, and highlighting impactful research Scale: Researchers, scientists, and industry professionals from across the globe Cost: Free for members of the MGB research community; registration policies vary for external participants.
The MGB Gene and Cell Therapy Research Symposium focuses on advancing gene and cell therapy innovations, accelerating clinical translation, and highlighting impactful research. The meeting will include keynote presentations from leading figures in the field, scientific talks spanning the research and clinical landscape, and a poster session showcasing emerging research and novel discoveries. The symposium’s Spark Grant program funds gene and cell therapy projects that demonstrate tangible advancements toward clinical applications with commercialization outcomes including licensing, partnerships, and new company creation. The grant program attracts founders and VCs to the meeting as a way to scout IP that hasn’t gone public.
International mRNA Health Conference
Date: November 17–19, 2026 Location: Westin Copley Place, Boston; virtual Purpose: Advancing the science and business of mRNA medicines Scale: 850 + attendees Cost: Onsite fee range from $900 to $1,850; Online fee range from $450 to $750; early bird discount offered until August 17
The International mRNA Health Conference is focused on advancing the science and business of mRNA medicines and covering infectious diseases, oncology, rare diseases, and more. The program showcases the latest advances in mRNA and LNP research, platform technologies, clinical development, and manufacturing. Many attendees have deep knowledge of working on mRNA before 2021.
